↓ Skip to main content

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Overview of attention for article published in Journal of Clinical Oncology, December 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs
1 blog
twitter
47 X users

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Published in
Journal of Clinical Oncology, December 2021
DOI 10.1200/jco.21.02538
Pubmed ID
Authors

Nancy N Baxter, Erin B Kennedy, Emily Bergsland, Jordan Berlin, Thomas J George, Sharlene Gill, Philip J Gold, Alex Hantel, Lee Jones, Christopher Lieu, Najjia Mahmoud, Arden M Morris, Erika Ruiz-Garcia, Y Nancy You, Jeffrey A Meyerhardt

X Demographics

X Demographics

The data shown below were collected from the profiles of 47 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Other 12 11%
Student > Ph. D. Student 11 10%
Student > Doctoral Student 9 8%
Researcher 8 8%
Student > Master 8 8%
Other 18 17%
Unknown 40 38%
Readers by discipline Count As %
Medicine and Dentistry 37 35%
Biochemistry, Genetics and Molecular Biology 7 7%
Nursing and Health Professions 3 3%
Agricultural and Biological Sciences 3 3%
Unspecified 3 3%
Other 13 12%
Unknown 40 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2022.
All research outputs
#1,203,772
of 25,392,582 outputs
Outputs from Journal of Clinical Oncology
#2,949
of 22,059 outputs
Outputs of similar age
#29,523
of 513,767 outputs
Outputs of similar age from Journal of Clinical Oncology
#82
of 221 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,059 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 513,767 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 221 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.